208 tracked 13F filers disclose a position in TNGX as of the latest SEC 13F filings, a combined $4.3B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | RTW INVESTMENTS, LP | $434.5M | 13.9M | ▲+4.5% Added · +600K sh | Q2 2026 | |
| 2 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $268.0M | 12.8M | ▲+21% Added · +2.2M sh | Q1 2026 | |
| 3 | Boxer Capital Management, LLC | $227.5M | 10.9M | —Held | Q1 2026 | |
| 4 | TCG Crossover Management, LLC | $220.3M | 10.5M | ▼−17% Reduced · −2.2M sh | Q1 2026 | |
| 5 | FMR LLC | $207.2M | 9.9M | ▲+245% Added · +7.0M sh | Q1 2026 | |
| 6 | FARALLON CAPITAL MANAGEMENT LLC | $190.3M | 9.1M | ▼−30% Reduced · −4.0M sh | Q1 2026 | |
| 7 | BlackRock, Inc. | $183.0M | 8.7M | ▲+2.4% Added · +207K sh | Q1 2026 | |
| 8 | Woodline Partners LP | $167.4M | 8.0M | ▼−21% Reduced · −2.1M sh | Q1 2026 | |
| 9 | Nextech Invest, Ltd. | $152.0M | 7.3M | —Held | Q1 2026 | |
| 10 | TRV GP IV, LLC | $120.2M | 6.4M | —Held | Q2 2026 | |
| 11 | Siren, L.L.C. | $193.2M | 6.2M | ▲+9.2% Added · +522K sh | Q2 2026 | |
| 12 | STATE STREET CORP | $186.9M | 6.0M | ▲+29% Added · +1.3M sh | Q2 2026 | |
| 13 | VANGUARD CAPITAL MANAGEMENT LLC | $108.0M | 5.2M | →First observed position No prior filed position | Q1 2026 | |
| 14 | GOLDMAN SACHS GROUP INC | $106.2M | 5.1M | ▲+2.7% Added · +134K sh | Q1 2026 | |
| 15 | DEERFIELD MANAGEMENT COMPANY, L.P. | $86.8M | 4.1M | ▲+43% Added · +1.2M sh | Q1 2026 | |
| 16 | Paradigm Biocapital Advisors LP | $83.9M | 4.0M | ▲New +4.0M sh | Q1 2026 | |
| 17 | Holocene Advisors, LP | $82.3M | 3.9M | ▲New +3.9M sh | Q1 2026 | |
| 18 | BALYASNY ASSET MANAGEMENT L.P. | $80.1M | 3.8M | ▼−28% Reduced · −1.5M sh | Q1 2026 | |
| 19 | GEODE CAPITAL MANAGEMENT, LLC | $117.0M | 3.7M | ▲+40% Added · +1.1M sh | Q2 2026 | |
| 20 | Logos Global Management LP | $62.8M | 3.0M | ▼−29% Reduced · −1.2M sh | Q1 2026 | |
| 21 | Deep Track Capital, LP | $57.5M | 2.8M | ▲+12% Added · +295K sh | Q1 2026 | |
| 22 | Caligan Partners LP | $50.4M | 2.4M | ▼−35% Reduced · −1.3M sh | Q1 2026 | |
| 23 | JANUS HENDERSON GROUP PLC | $50.1M | 2.4M | ▼−9.4% Reduced · −249K sh | Q1 2026 | |
| 24 | Jefferies Financial Group Inc. | $62.8M | 2.0M | ▲New +2.0M sh | Q2 2026 | |
| 25 | Candriam S.C.A. | $50.9M | 1.6M | ▲+28% Added · +361K sh | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 17 funds opened a new position in TNGX and 27 added to an existing one, while 21 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 109 funds | $59.3B |
| NVIDIA CORPNVDA | 108 funds | $307.2B |
| AMAZON.COM INCAMZN | 108 funds | $150.3B |
| REVOLUTION MEDICINES INCRVMD | 107 funds | $7.9B |
| MICROSOFT CORPMSFT | 105 funds | $204.0B |
| META PLATFORMS INC-CLASS AMETA | 102 funds | $86.2B |
| MERCK & CO. INC.MRK | 102 funds | $21.4B |
| ALPHABET INC-CL AGOOGL | 101 funds | $125.0B |
| UNITEDHEALTH GROUP INCUNH | 101 funds | $21.7B |
| BROADCOM INCAVGO | 100 funds | $119.0B |
| MICRON TECHNOLOGY INCMU | 100 funds | $27.5B |
| LAM RESEARCH CORPLRCX | 99 funds | $25.4B |
Ranked by how many of TNGX's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 3, 2026 | Crystal Adam | President, R&D | Sell (S) | 5K | $141K |
| Aug 3, 2026 | Crystal Adam | President, R&D | Sell (S) | 22K | $594K |
| Jul 1, 2026 | Crystal Adam | President, R&D | Sell (S) | 20K | $576K |
| Jul 1, 2026 | Crystal Adam | President, R&D | Sell (S) | 7K | $223K |
| Jun 1, 2026 | Crystal Adam | President, R&D | Sell (S) | 6K | $137K |
| Jun 1, 2026 | Crystal Adam | President, R&D | Sell (S) | 21K | $481K |
| May 1, 2026 | Crystal Adam | President, R&D | Sell (S) | 26K | $549K |
| May 1, 2026 | Crystal Adam | President, R&D | Sell (S) | 1K | $24K |
| Apr 15, 2026 | Crystal Adam | President, R&D | Sell (S) | 38K | $962K |
| Apr 1, 2026 | Crystal Adam | President, R&D | Sell (S) | 27K | $572K |
| Mar 25, 2026 | Crystal Adam | President, R&D | Sell (S) | 12K | $241K |
| Mar 5, 2026 | Crystal Adam | President, R&D | Sell (S) | 20K | $304K |
Connected entities for TNGX
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/TNGX/capital-change-brief"
Use Arkolith's capital_change_brief for TNGX. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for TNGX. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.